跳至主要内容
临床试验/NCT00670761
NCT00670761已完成不适用

Misoprostol for the Treatment of Incomplete Abortion: Comparison of Treatment Options

Gynuity Health Projects6 个研究点 分布在 5 个国家目标入组 720 人开始时间: 2004年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
720
试验地点
6
主要终点
complete resolution of signs/symptoms of incomplete abortion without recourse to surgery at any point for any reason

研究概览

简要总结

This randomized study will examine the efficacy, safety and acceptability of misoprostol for treatment of incomplete abortion.

Women diagnosed with incomplete abortion will be randomized to receive one of the following regimens:

In Tanzania and Mozambique:

  1. 600 mcg of oral misoprostol in one dose, or
  2. Standard surgical treatment (MVA)

In Moldova and Madagascar:

  1. 600 mcg of oral misoprostol in one dose, or
  2. 400 mcg of sublingual misoprostol in one dose.

In Burkina Faso and Vietnam:

  1. 400 mcg of sublingual misoprostol in one dose.

We hypothesize that treatment of incomplete abortion with either 400 mcg sublingual misoprostol, 600 mcg oral misoprostol or MVA are equally effective in evacuating the uterus.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • If no ultrasound used:
  • Past or present history of vaginal bleeding during pregnancy; and
  • Open cervical os.
  • If ultrasound used:
  • Past or present history of vaginal bleeding during pregnancy; and
  • Evidence of incomplete abortion with substantial debris in the uterus.
  • All women would have been advised to have surgical evacuation of the uterus if misoprostol was not available.
  • Willing to provide contact information for purposes of follow-up.
  • In Tanzania: 18 years of age or over or parental permission
  • In Mozambique: 21 years of age or over or parental permission
  • In Moldova: 18 years of age or over
  • In Madagascar: 18 years of age or parental permission
  • In Vietnam: reproductive age

排除标准

  • Contraindications to the study drug;
  • Uterine size larger than 12 weeks L.M.P. at time of presentation for care.
  • Signs of severe infection, defined as at least one of the following of:
  • foul smelling discharge,
  • fever > 39 degrees C ,
  • pulse >110/min;

研究组 & 干预措施

1

Active Comparator

treatment with 600mcg oral misoprostol

干预措施: misoprostol (Drug)

2

Active Comparator

treatment with 400mcg sublingual misoprostol

干预措施: misoprostol (Drug)

3

Active Comparator

treatment with Manual Vacuum Aspiration (MVA)

干预措施: MVA (Procedure)

结局指标

主要结局

complete resolution of signs/symptoms of incomplete abortion without recourse to surgery at any point for any reason

时间窗: one week after initial treatment with the option of an additional week

次要结局

未报告次要终点

研究者

发起方
Gynuity Health Projects
申办方类型
Other
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验